Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-086153

Options or other derivatives

  • Chief Operating Officer acquired 155,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yonehiro Grant · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +155,000 155,000 D
Loading xslF345X05/ownership.xml…